Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Physiological and Biological Responses to Short-Term Intermittent Hypobaric Hypoxia Exposure: From Sports and Mountain Medicine to New Biomedical Applications.

Viscor G, Torrella JR, Corral L, Ricart A, Javierre C, Pages T, Ventura JL.

Front Physiol. 2018 Jul 9;9:814. doi: 10.3389/fphys.2018.00814. eCollection 2018. Review.

2.

Outcomes of Advanced Hodgkin Lymphoma after Umbilical Cord Blood Transplantation: A Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party Study.

Paviglianiti A, Tozatto Maio K, Rocha V, Gehlkopf E, Milpied N, Esquirol A, Chevallier P, Blaise D, Gac AC, Leblond V, Cahn JY, Abecasis M, Zuckerman T, Schouten H, Gurman G, Rubio MT, Beguin Y, Corral LL, Nagler A, Snowden JA, Koc Y, Mordini N, Bonifazi F, Volt F, Kenzey C, Robinson SP, Montoto S, Gluckman E, Ruggeri A.

Biol Blood Marrow Transplant. 2018 Nov;24(11):2265-2270. doi: 10.1016/j.bbmt.2018.07.019. Epub 2018 Jul 19.

3.

A novel fibroblast activation inhibitor attenuates left ventricular remodeling and preserves cardiac function in heart failure.

Bradley JM, Spaletra P, Li Z, Sharp TE 3rd, Goodchild TT, Corral LG, Fung L, Chan KWH, Sullivan RW, Swindlehurst CA, Lefer DJ.

Am J Physiol Heart Circ Physiol. 2018 Sep 1;315(3):H563-H570. doi: 10.1152/ajpheart.00603.2017. Epub 2018 Jun 27.

PMID:
29949382
4.

T-cell replete haploidentical stem cell transplantation attenuates the prognostic impact of FLT3-ITD in acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Canaani J, Labopin M, Huang XJ, Arcese W, Ciceri F, Blaise D, Irrera G, Corral LL, Bruno B, Santarone S, Van Lint MT, Vitek A, Esteve J, Mohty M, Nagler A.

Am J Hematol. 2018 Jun;93(6):736-744. doi: 10.1002/ajh.25082. Epub 2018 Mar 23.

5.

Reply to Robinson et al.: Building the evidence base on the forest cover effects of community titling.

Blackman A, Corral L, Lima ES, Asner GP.

Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):E5765. doi: 10.1073/pnas.1708942114. Epub 2017 Jun 23. No abstract available.

6.

Titling indigenous communities protects forests in the Peruvian Amazon.

Blackman A, Corral L, Lima ES, Asner GP.

Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):4123-4128. doi: 10.1073/pnas.1603290114. Epub 2017 Apr 3.

7.

Haplo-Cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML.

Kwon M, Bautista G, Balsalobre P, Sánchez-Ortega I, Montesinos P, Bermúdez A, de Laiglesia A, Herrera P, Martin C, Humala K, Zabalza A, Torres M, Bento L, Corral LL, Heras I, Serrano D, Buño I, Anguita J, Regidor C, Duarte R, Cabrera R, Gayoso J, Diez-Martin JL.

Bone Marrow Transplant. 2017 Aug;52(8):1138-1143. doi: 10.1038/bmt.2017.36. Epub 2017 Mar 27.

PMID:
28346415
8.

Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial.

Mateos MV, Hernández MT, Giraldo P, de la Rubia J, de Arriba F, Corral LL, Rosiñol L, Paiva B, Palomera L, Bargay J, Oriol A, Prosper F, López J, Arguiñano JM, Quintana N, García JL, Bladé J, Lahuerta JJ, Miguel JS.

Lancet Oncol. 2016 Aug;17(8):1127-1136. doi: 10.1016/S1470-2045(16)30124-3. Epub 2016 Jul 9.

PMID:
27402145
9.

In patients older than 55 years with AML in first CR, should we search for a matched unrelated donor when an old sibling donor is available?

Peffault de Latour R, Labopin M, Cornelissen J, Vigouroux S, Craddock C, Blaise D, Huyn A, Vindelov L, Maertens J, Chevallier P, Fegueux N, Socié G, Cahn JY, Petersen E, Schouten H, Lioure B, Russell N, Corral LL, Ciceri F, Nagler A, Mohty M; Acute Leukemia Working Party of EBMT.

Bone Marrow Transplant. 2015 Nov;50(11):1411-5. doi: 10.1038/bmt.2015.180. Epub 2015 Sep 14.

PMID:
26367237
10.

Nodal monoclonal CD5-positive B-lymphocytosis and toxoplasma lymphadenitis: another variant in the spectrum of infectious lymphadenitis in patients with chronic leukemia/small lymphocytic lymphoma.

Pagni F, L'Imperio V, Cazzaniga G, Corral L, Doni E, Isimbaldi G.

Expert Rev Hematol. 2015 Oct;8(5):563-5. doi: 10.1586/17474086.2015.1061281. Epub 2015 Aug 20. No abstract available.

PMID:
26295844
11.

CD34+ circulating progenitor cells after different training programs.

Niño O, Balague N, Aragones D, Blasi J, Alamo JM, Corral L, Javierre C, Miguel M, Viscor G, Ventura JL.

Int J Sports Med. 2015 Apr;36(4):292-6. doi: 10.1055/s-0034-1394394. Epub 2014 Nov 27.

PMID:
25429550
12.

Intermittent hypoxia for obstructive sleep apnea?

Viscor G, Ricart A, Pagès T, Corral L, Javierre CF, Ventura JL.

High Alt Med Biol. 2014 Dec;15(4):520-1. doi: 10.1089/ham.2014.1060. No abstract available.

PMID:
25361383
13.

Circulating progenitor cells during exercise, muscle electro-stimulation and intermittent hypobaric hypoxia in patients with traumatic brain injury: a pilot study.

Corral L, Conde L, Guillamó E, Blasi J, Juncadella M, Javierre C, Viscor G, Ventura JL.

NeuroRehabilitation. 2014;35(4):763-9. doi: 10.3233/NRE-141172.

PMID:
25318779
14.

Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs.

Chamberlain PP, Lopez-Girona A, Miller K, Carmel G, Pagarigan B, Chie-Leon B, Rychak E, Corral LG, Ren YJ, Wang M, Riley M, Delker SL, Ito T, Ando H, Mori T, Hirano Y, Handa H, Hakoshima T, Daniel TO, Cathers BE.

Nat Struct Mol Biol. 2014 Sep;21(9):803-9. doi: 10.1038/nsmb.2874. Epub 2014 Aug 10.

PMID:
25108355
15.

Lenalidomide inhibits the proliferation of CLL cells via a cereblon/p21(WAF1/Cip1)-dependent mechanism independent of functional p53.

Fecteau JF, Corral LG, Ghia EM, Gaidarova S, Futalan D, Bharati IS, Cathers B, Schwaederlé M, Cui B, Lopez-Girona A, Messmer D, Kipps TJ.

Blood. 2014 Sep 4;124(10):1637-44. doi: 10.1182/blood-2014-03-559591. Epub 2014 Jul 2.

16.

Combined intermittent hypobaric hypoxia and muscle electro-stimulation: a method to increase circulating progenitor cell concentration?

Corral L, Javierre C, Blasi J, Viscor G, Ricart A, Ventura JL.

J Transl Med. 2014 Jun 19;12:174. doi: 10.1186/1479-5876-12-174.

17.

Clonal variegation and dynamic competition of leukemia-initiating cells in infant acute lymphoblastic leukemia with MLL rearrangement.

Bardini M, Woll PS, Corral L, Luc S, Wittmann L, Ma Z, Lo Nigro L, Basso G, Biondi A, Cazzaniga G, Jacobsen SE.

Leukemia. 2015 Jan;29(1):38-50. doi: 10.1038/leu.2014.154. Epub 2014 May 6.

PMID:
24798483
18.

The role of PAX5 and C/EBP α/β in atypical non-Langerhans cell histiocytic tumor post acute lymphoblastic leukemia.

Pagni F, Fazio G, Zannella S, Spinelli M, De Angelis C, Cusi C, Crosti F, Corral L, Bugarin C, Biondi A, Cazzaniga G, Isimbaldi G, Cattoretti G.

Leukemia. 2014 Jun;28(6):1377-9. doi: 10.1038/leu.2014.87. Epub 2014 Feb 25. No abstract available. Erratum in: Leukemia. 2014 Jun;28(6):1380.

PMID:
24569775
19.

Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation score allows a better stratification of high-risk patients undergoing reduced-toxicity allogeneic hematopoietic cell transplantation.

Barba P, Martino R, Pérez-Simón JA, Fernández-Avilés F, Castillo N, Piñana JL, López-Anglada L, Rovira M, Bosch F, Carreras E, Corral LL, Sierra J, Valcárcel D.

Biol Blood Marrow Transplant. 2014 Jan;20(1):66-72. doi: 10.1016/j.bbmt.2013.10.011. Epub 2013 Oct 17.

20.

Isosteric analogs of lenalidomide and pomalidomide: synthesis and biological activity.

Ruchelman AL, Man HW, Zhang W, Chen R, Capone L, Kang J, Parton A, Corral L, Schafer PH, Babusis D, Moghaddam MF, Tang Y, Shirley MA, Muller GW.

Bioorg Med Chem Lett. 2013 Jan 1;23(1):360-5. doi: 10.1016/j.bmcl.2012.10.071. Epub 2012 Oct 27.

PMID:
23168019
21.

Impact of non-neurological complications in severe traumatic brain injury outcome.

Corral L, Javierre CF, Ventura JL, Marcos P, Herrero JI, Mañez R.

Crit Care. 2012 Dec 12;16(2):R44. doi: 10.1186/cc11243.

22.

Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice.

Meiler SE, Wade M, Kutlar F, Yerigenahally SD, Xue Y, Moutouh-de Parseval LA, Corral LG, Swerdlow PS, Kutlar A.

Blood. 2011 Jul 28;118(4):1109-12. doi: 10.1182/blood-2010-11-319137. Epub 2011 May 2.

23.

Refractory nonconvulsive status epilepticus in Creutzfeldt-Jakob disease.

Aiguabella M, Falip M, Veciana M, Bruna J, Palasí A, Corral L, Herrero JI, Boluda S, Mora J, Iranzo A, Serrano C.

Epileptic Disord. 2010 Sep;12(3):239-42. doi: 10.1684/epd.2010.0318. Epub 2010 Jul 19.

24.

DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4.

Bardini M, Spinelli R, Bungaro S, Mangano E, Corral L, Cifola I, Fazio G, Giordan M, Basso G, De Rossi G, Biondi A, Battaglia C, Cazzaniga G.

Leukemia. 2010 Jan;24(1):169-76. doi: 10.1038/leu.2009.203. Epub 2009 Nov 12.

PMID:
19907438
25.

IGH and IGK gene rearrangements as PCR targets for pediatric Burkitt's lymphoma and mature B-ALL MRD analysis.

Lovisa F, Mussolin L, Corral L, Pillon M, Cazzaniga G, Biondi A, Rosolen A.

Lab Invest. 2009 Oct;89(10):1182-6. doi: 10.1038/labinvest.2009.81. Epub 2009 Aug 10.

26.

Immunomodulatory drugs reorganize cytoskeleton by modulating Rho GTPases.

Xu Y, Li J, Ferguson GD, Mercurio F, Khambatta G, Morrison L, Lopez-Girona A, Corral LG, Webb DR, Bennett BL, Xie W.

Blood. 2009 Jul 9;114(2):338-45. doi: 10.1182/blood-2009-02-200543. Epub 2009 May 5.

27.

First CT findings and improvement in GOS and GOSE scores 6 and 12 months after severe traumatic brain injury.

Corral L, Herrero JI, Monfort JL, Ventura JL, Javierre CF, Juncadella M, García-Huete L, Bartolomé C, Gabarrós A.

Brain Inj. 2009 May;23(5):403-10. doi: 10.1080/02699050902788477.

PMID:
19301165
28.

Discovery of (S)-N-[2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl] acetamide (apremilast), a potent and orally active phosphodiesterase 4 and tumor necrosis factor-alpha inhibitor.

Man HW, Schafer P, Wong LM, Patterson RT, Corral LG, Raymon H, Blease K, Leisten J, Shirley MA, Tang Y, Babusis DM, Chen R, Stirling D, Muller GW.

J Med Chem. 2009 Mar 26;52(6):1522-4. doi: 10.1021/jm900210d.

PMID:
19256507
29.

Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol.

Van der Velden VH, Corral L, Valsecchi MG, Jansen MW, De Lorenzo P, Cazzaniga G, Panzer-Grümayer ER, Schrappe M, Schrauder A, Meyer C, Marschalek R, Nigro LL, Metzler M, Basso G, Mann G, Den Boer ML, Biondi A, Pieters R, Van Dongen JJ; Interfant-99 Study Group.

Leukemia. 2009 Jun;23(6):1073-9. doi: 10.1038/leu.2009.17. Epub 2009 Feb 12.

PMID:
19212338
30.

Is C-reactive protein a biomarker for immediate clinical outcome after cardiac surgery?

Corral L, Carrió ML, Ventura JL, Torrado H, Javierre C, Rodriguez-Castro D, Farrero E, Valero J, Ortiz D.

J Cardiothorac Vasc Anesth. 2009 Apr;23(2):166-9. doi: 10.1053/j.jvca.2008.11.014. Epub 2009 Feb 7.

PMID:
19201207
31.

Immunomodulatory drugs Revlimid (lenalidomide) and CC-4047 induce apoptosis of both hematological and solid tumor cells through NK cell activation.

Zhu D, Corral LG, Fleming YW, Stein B.

Cancer Immunol Immunother. 2008 Dec;57(12):1849-59. doi: 10.1007/s00262-008-0512-7. Epub 2008 Apr 8.

PMID:
18392823
32.

Targeting the p27 E3 ligase SCF(Skp2) results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy.

Chen Q, Xie W, Kuhn DJ, Voorhees PM, Lopez-Girona A, Mendy D, Corral LG, Krenitsky VP, Xu W, Moutouh-de Parseval L, Webb DR, Mercurio F, Nakayama KI, Nakayama K, Orlowski RZ.

Blood. 2008 May 1;111(9):4690-9. doi: 10.1182/blood-2007-09-112904. Epub 2008 Feb 27.

33.

Improvement in GOS and GOSE scores 6 and 12 months after severe traumatic brain injury.

Corral L, Ventura JL, Herrero JI, Monfort JL, Juncadella M, Gabarrós A, Bartolomé C, Javierre CF, García-Huete L.

Brain Inj. 2007 Nov;21(12):1225-31. doi: 10.1080/02699050701727460.

PMID:
18236198
34.

Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells.

Moutouh-de Parseval LA, Verhelle D, Glezer E, Jensen-Pergakes K, Ferguson GD, Corral LG, Morris CL, Muller G, Brady H, Chan K.

J Clin Invest. 2008 Jan;118(1):248-58.

35.

The tumor suppressor PP2A Abeta regulates the RalA GTPase.

Sablina AA, Chen W, Arroyo JD, Corral L, Hector M, Bulmer SE, DeCaprio JA, Hahn WC.

Cell. 2007 Jun 1;129(5):969-82.

36.

Immunomodulatory drug CC-4047 is a cell-type and stimulus-selective transcriptional inhibitor of cyclooxygenase 2.

Ferguson GD, Jensen-Pergakes K, Wilkey C, Jhaveri U, Richard N, Verhelle D, De Parseval LM, Corral LG, Xie W, Morris CL, Brady H, Chan K.

J Clin Immunol. 2007 Mar;27(2):210-20. Epub 2007 Feb 17.

PMID:
17308870
37.

Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement.

Jansen MW, Corral L, van der Velden VH, Panzer-Grümayer R, Schrappe M, Schrauder A, Marschalek R, Meyer C, den Boer ML, Hop WJ, Valsecchi MG, Basso G, Biondi A, Pieters R, van Dongen JJ.

Leukemia. 2007 Apr;21(4):633-41. Epub 2007 Feb 1.

PMID:
17268512
38.

Lenalidomide and CC-4047 inhibit the proliferation of malignant B cells while expanding normal CD34+ progenitor cells.

Verhelle D, Corral LG, Wong K, Mueller JH, Moutouh-de Parseval L, Jensen-Pergakes K, Schafer PH, Chen R, Glezer E, Ferguson GD, Lopez-Girona A, Muller GW, Brady HA, Chan KW.

Cancer Res. 2007 Jan 15;67(2):746-55.

39.

B7-h4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer.

Simon I, Zhuo S, Corral L, Diamandis EP, Sarno MJ, Wolfert RL, Kim NW.

Cancer Res. 2006 Feb 1;66(3):1570-5.

40.

The synthetic compound CC-5079 is a potent inhibitor of tubulin polymerization and tumor necrosis factor-alpha production with antitumor activity.

Zhang LH, Wu L, Raymon HK, Chen RS, Corral L, Shirley MA, Narla RK, Gamez J, Muller GW, Stirling DI, Bartlett JB, Schafer PH, Payvandi F.

Cancer Res. 2006 Jan 15;66(2):951-9.

41.

Donors with positive blood culture: could they transmit infections to the recipients?

González-Segura C, Pascual M, García Huete L, Cañizares R, Torras J, Corral L, Santos P, Ramos R, Pujol M.

Transplant Proc. 2005 Nov;37(9):3664-6.

PMID:
16386498
42.

B7-H4 overexpression in ovarian tumors.

Tringler B, Liu W, Corral L, Torkko KC, Enomoto T, Davidson S, Lucia MS, Heinz DE, Papkoff J, Shroyer KR.

Gynecol Oncol. 2006 Jan;100(1):44-52. Epub 2005 Oct 26.

PMID:
16256178
43.
44.

Testisin, a glycosyl-phosphatidylinositol-linked serine protease, promotes malignant transformation in vitro and in vivo.

Tang T, Kmet M, Corral L, Vartanian S, Tobler A, Papkoff J.

Cancer Res. 2005 Feb 1;65(3):868-78.

45.

Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements.

Lanciotti M, Dufour C, Corral L, Di Michele P, Pigullo S, De Rossi G, Basso G, Leszl A, Luciani M, Lo Nigro L, Micalizzi C, Valsecchi MG, Biondi A, Haupt R.

Leukemia. 2005 Feb;19(2):214-6.

PMID:
15618957
46.

A prospective, randomized study in critically ill patients using the Oligon Vantex catheter.

Corral L, Nolla-Salas M, Ibañez-Nolla J, León MA, Díaz RM, Cruz Martín M, Iglesia R, Catalan R.

J Hosp Infect. 2003 Nov;55(3):212-9.

PMID:
14572489
47.

Alpha-fluoro-substituted thalidomide analogues.

Man HW, Corral LG, Stirling DI, Muller GW.

Bioorg Med Chem Lett. 2003 Oct 20;13(20):3415-7.

PMID:
14505639
48.

Molecular remission induced by gemtuzumab ozogamicin associated with donor lymphocyte infusions in t(4;11) acute lymphoblastic leukemia relapsed after transplantation.

Balduzzi A, Rossi V, Corral L, Bonanomi S, Longoni D, Rovelli A, Conter V, Biondi A, Uderzo C.

Leukemia. 2003 Nov;17(11):2247-8. No abstract available.

PMID:
12960967
49.
50.

Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs.

Schafer PH, Gandhi AK, Loveland MA, Chen RS, Man HW, Schnetkamp PP, Wolbring G, Govinda S, Corral LG, Payvandi F, Muller GW, Stirling DI.

J Pharmacol Exp Ther. 2003 Jun;305(3):1222-32. Epub 2003 Mar 20.

PMID:
12649301

Supplemental Content

Loading ...
Support Center